亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Pharmacological pain management in patients with rheumatoid arthritis: a narrative literature review

医学 类风湿性关节炎 叙述性评论 疼痛管理 重症监护医学 替代医学 梅德林 物理疗法 皮肤病科 内科学 病理 政治学 法学
作者
Natasha Cox,Christian Mallen,Ian C. Scott
出处
期刊:BMC Medicine [BioMed Central]
卷期号:23 (1)
标识
DOI:10.1186/s12916-025-03870-0
摘要

Pain is a major challenge for patients with rheumatoid arthritis (RA), with many people suffering chronic pain. Current RA management guidelines focus on assessing and reducing disease activity using disease-modifying anti-rheumatic drugs (DMARDs). Consequently, pain care is often suboptimal, with growing evidence that analgesics are widely prescribed to patients with RA, despite potential toxicities and limited evidence for efficacy. Our review provides an overview of pharmacological treatments for pain in patients with RA, summarising their efficacy and use. Thirteen systematic reviews of drug efficacy for pain in patients with RA were included in this review. These showed moderate- to high-quality evidence from clinical trials in more contemporary time-periods (mainly 1990s/2000s for synthetic DMARDs and post-2000 for biological/targeted synthetic DMARDs) that, in patients with active RA, short-term glucocorticoids and synthetic, biologic, and targeted synthetic DMARDs have efficacy at reducing pain intensity relative to placebo. In contrast, they showed low-quality evidence from trials in more historical time-periods (mainly in the 1960s-1990s for opioids and paracetamol) that (aside from naproxen) analgesics/neuromodulators provide any improvements in pain relative to placebo, and no supportive evidence for gabapentinoids, or long-term opioids. Despite this evidence base, 21 studies of analgesic prescribing in patients with RA consistently showed substantial and sustained prescribing of analgesics, particularly opioids, with approximately one quarter and > 40% of patients receiving chronic opioid prescriptions in each year in England and North America, respectively. Whilst NSAID prescribing had fallen over time across countries, gabapentinoid prescribing in England had risen from < 1% of patients in 2004 to approximately 10% in 2020. Prescribing levels varied substantially between individual clinicians and groups of patients. In patients with active RA, DMARDs have efficacy at reducing pain, supporting the role of treat-to-target strategies. Despite limited evidence that analgesics improve pain in patients with RA, these medicines are widely prescribed. The reasons for this are unclear. We consider that closing this evidence-to-practice gap requires qualitative research exploring the drivers of this practice, high-quality trials of analgesic efficacy in contemporary RA populations, alongside an increased focus on pain management (including pharmacological and non-pharmacological options) within RA guidelines.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
molihuakai的应助被科研通管家采纳,获得10
10秒前
11秒前
英俊的谷蓝完成签到,获得积分10
15秒前
明理的璎完成签到,获得积分10
33秒前
37秒前
美丽的忆彤完成签到,获得积分10
38秒前
Ava的应助被sun采纳,获得10
54秒前
1分钟前
动听一德完成签到,获得积分10
1分钟前
领导范儿的应助被ClaraClark591采纳,获得30
1分钟前
1分钟前
1分钟前
sun发布了新的文献求助10
1分钟前
ClaraClark591发布了新的文献求助30
1分钟前
威武的又琴完成签到,获得积分10
1分钟前
闪闪小凡完成签到,获得积分10
1分钟前
1分钟前
369ninja发布了新的文献求助10
1分钟前
Tashanzhishi完成签到,获得积分10
1分钟前
优美的烙完成签到,获得积分10
2分钟前
打打的应助被科研通管家采纳,获得10
2分钟前
2分钟前
2分钟前
科目三的应助被科研通管家采纳,获得10
2分钟前
奔跑的应助被科研通管家采纳,获得10
2分钟前
愉快的惋庭完成签到,获得积分10
2分钟前
等待剑完成签到,获得积分10
2分钟前
2分钟前
Maestro_S的应助被爱学习的doge采纳,获得10
2分钟前
2分钟前
3分钟前
孙老师完成签到 ,获得积分10
3分钟前
AiQi完成签到 ,获得积分10
3分钟前
sfwrbh完成签到,获得积分10
3分钟前
多情的中蓝完成签到,获得积分10
3分钟前
甜蜜语堂完成签到,获得积分10
3分钟前
李爱国的应助被科研通管家采纳,获得10
4分钟前
Maestro_S的应助被科研通管家采纳,获得10
4分钟前
大医仁心完成签到 ,获得积分0
4分钟前
Ali发布了新的文献求助10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179956
求助须知:如何正确求助?哪些是违规求助? 9570170
关于积分的说明 21808444
捐赠科研通 7775818
什么是DOI,文献DOI怎么找? 3433251
关于科研通互助平台的介绍 2557352
邀请新用户注册赠送积分活动 2478958